These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

44 related articles for article (PubMed ID: 729356)

  • 1. In vitro inhibition of monoamine oxidase types A and B by d- and l-amphetamine.
    Miller HH; Clarke DE
    Commun Psychopharmacol; 1978; 2(4):319-25. PubMed ID: 729356
    [No Abstract]   [Full Text] [Related]  

  • 2. Rat heart monoamine oxidase: antagonism between d-amphetamine, oleic and arachidonic acids and monoamine oxidase inhibitors.
    Sen R; Parmar SS; Guha SR
    Proc West Pharmacol Soc; 1979; 22():109-13. PubMed ID: 515037
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoamine oxidase inhibition by (+)-amphetamine in vivo [proceedings].
    Clarke DE; Miller HH; Shore PA
    Br J Pharmacol; 1979 Jul; 66(3):435P-436P. PubMed ID: 526724
    [No Abstract]   [Full Text] [Related]  

  • 4. In vivo monoamine oxidase inhibition by d-amphetamine.
    Miller HH; Shore PA; Clarke DE
    Biochem Pharmacol; 1980 May; 29(10):1347-54. PubMed ID: 6901611
    [No Abstract]   [Full Text] [Related]  

  • 5. D-amphetamine and DL-alpha-N-methyltryptamine eliminate the irreversible inhibition of mitochondrial monoamine oxidase, caused by clorgyline. The specific action on the tyramine oxidation.
    Severina IS
    Biochem Int; 1984 Aug; 9(2):219-28. PubMed ID: 6487343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-amphetamine-induced hydrogen peroxide production in skeletal muscle is modulated by monoamine oxidase inhibition.
    Duarte JA; Carvalho F; Fernandes E; Remião F; Bastos ML; Magalhães J; Appell HJ
    Int J Sports Med; 2004 Aug; 25(6):446-9. PubMed ID: 15346233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of D-L amphetamine sulphate on the oxygen and glucose uptake and oxidative phosphorylation of rat brain "in vitro" (author's transl)].
    González JL; Saiz I; Velasco A
    Arch Farmacol Toxicol; 1977 Aug; 3(2):177-80. PubMed ID: 921337
    [No Abstract]   [Full Text] [Related]  

  • 8. [INTERFERENCE BY D-AMPHETAMINE IN THE ACTION OF SOME MONOAMINE OXIDASE INHIBITORS].
    FERRI S; MAFFEI-FACCIOLI A; ORNESI A; SCAMAZZO T
    Boll Soc Ital Biol Sper; 1963 Nov; 39():1381-4. PubMed ID: 14123621
    [No Abstract]   [Full Text] [Related]  

  • 9. The role of intraneuronal monoamine oxidase on the sympathomimetic response to amphetamine.
    Obianwu HO
    Acta Pharmacol Toxicol (Copenh); 1970; 28(1):69. PubMed ID: 5314439
    [No Abstract]   [Full Text] [Related]  

  • 10. D & L amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons.
    Bunney BS; Walters JR; Kuhar MJ; Roth RH; Aghajanian GK
    Psychopharmacol Commun; 1975; 1(2):177-90. PubMed ID: 1223998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relative effects of d-amphetamine, imipramine and harmaline on tetrabenazine suppression of schedule-controlled behavior in the rat.
    McKearney JW
    J Pharmacol Exp Ther; 1968 Feb; 159(2):429-40. PubMed ID: 5638662
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of d- and l- amphetamine on fixed-interval and fixed-ratio behavior in tolerant and nontolerant rats.
    Tilson HA; Sparber SB
    J Pharmacol Exp Ther; 1973 Nov; 187(2):372-9. PubMed ID: 4748553
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of types A and B monoamine oxidase by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Fuller RW; Hemrick-Luecke SK
    J Pharmacol Exp Ther; 1985 Mar; 232(3):696-701. PubMed ID: 3871853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the effects of amphetamine and its metabolites, p-hydroxyamphetamine and p-hydroxynorephedrine, on uptake, release and catabolism of 3H-norepinephrine in cerebral cortex of rat brain.
    Wenger GR; Rutledge CO
    J Pharmacol Exp Ther; 1974 Jun; 189(3):725-32. PubMed ID: 4152317
    [No Abstract]   [Full Text] [Related]  

  • 15. Mechanism of the adverse interaction between monoamine oxidase inhibitors and amphetamine.
    Simpson LL
    J Pharmacol Exp Ther; 1978 May; 205(2):392-9. PubMed ID: 646869
    [No Abstract]   [Full Text] [Related]  

  • 16. Monoamine oxidase inhibition by d-amphetamine in ganglia and nerve endings.
    Filinger EJ; Stefano FJ
    Experientia; 1982 Jul; 38(7):844-5. PubMed ID: 7106259
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood pressure and heart rate responses evoked by d- and l-amphetamine in the pithed rat preparation.
    Simpson LL
    J Pharmacol Exp Ther; 1975 Apr; 193(1):149-59. PubMed ID: 1133761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of monoamine oxidase inhibition on amphetamine-evoked changes in dopamine receptor availability in the living pig: a dual tracer PET study with [11C]harmine and [11C]raclopride.
    Jensen SB; Olsen AK; Pedersen K; Cumming P
    Synapse; 2006 Jun; 59(7):427-34. PubMed ID: 16485265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of dl-p-methoxyamphetamine and d-amphetamine on catecholamine release and reuptake in vitro.
    Tseng LF; Hitzemann RJ; Loh HH
    J Pharmacol Exp Ther; 1974 Jun; 189(3):708-16. PubMed ID: 4843169
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of mouse brain monoamine oxidase by (+)-amphetamine in vivo.
    Green AL; el Hait MA
    J Pharm Pharmacol; 1978 Apr; 30(4):262-3. PubMed ID: 24723
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.